| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.41 | 0.01 (+3.22%) | 0.375 - 2.43 | 1.5 million (Below Avg) |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 0.41 |
|---|---|
| Previous Close | 0.40 |
| Day's Range | 0.39 - 0.42 |
| Market Cap | 40.0M |
| Avg Volume (10 Day) | 2.4M |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.72 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm
PR Newswire - Saturday 05/18/2013 9:00 AM ET
Delcath Systems, Inc. Sued by Investor
PR Newswire - Friday 05/10/2013 7:09 PM ET
Delcath Systems Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
Business Wire - Friday 05/10/2013 4:57 PM ET
| DCTH | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 55.13 |
| Company | Last | Change |
|---|---|---|
| Intellipharmaceutics International Inc | 1.77 | -0.56% |
| Columbia Laboratories Inc | 0.65 | +0.23% |
| pSivida Corp | 2.83 | +1.43% |
| Acura Pharmaceuticals Inc | 2.35 | +7.31% |
| Flamel Technologies SA | 4.65 | +1.97% |
Data is delayed by at least 15 min.